Integra LifeSciences Holdings Corporation IART
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 231.27% | 197.10% | -170.95% | 68.47% | 98.88% |
| Total Depreciation and Amortization | 2.43% | -0.77% | 0.00% | -0.24% | 2.20% |
| Total Amortization of Deferred Charges | 4.51% | 2.51% | -1.97% | -22.81% | -30.42% |
| Total Other Non-Cash Items | -27.97% | -5.82% | 153.12% | 40.66% | -103.78% |
| Change in Net Operating Assets | 242.33% | 14.68% | -99.52% | -163.17% | 234.75% |
| Cash from Operations | 320.91% | 132.60% | -17.04% | -71.11% | 358.64% |
| Capital Expenditure | 16.75% | 17.11% | 13.74% | -13.58% | 24.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -3,995.60% | 71.24% |
| Cash from Investing | 76.33% | -191.51% | 57.46% | -123.94% | 27.99% |
| Total Debt Issued | -36.62% | -29.44% | -10.46% | -91.77% | 4,579.84% |
| Total Debt Repaid | -165.15% | 30.07% | -41.86% | 95.91% | -3,762.72% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | 6.54% | 84.44% | -903.65% | 31.16% | 55.38% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -78.67% | 99.58% |
| Cash from Financing | -5,558.68% | -109.86% | -65.91% | 337.60% | 51.54% |
| Foreign Exchange rate Adjustments | -45.84% | 26.56% | -192.55% | 301.12% | -106.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 269.00% | -1,371.66% | -38.47% | -79.95% | 167.35% |